Khandan Keyomarsi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Top Venues

Cancer research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hyemin Lee, Amber D Horbath, Lavanya Kondiparthi, Jitendra Kumar Meena, Guang Lei, Shayani Dasgupta, Xiaoguang Liu, Li Zhuang, Pranavi Koppula, Mi Li, Iqbal Mahmud, Bo Wei, Philip L Lorenzi, Khandan Keyomarsi, Masha V Poyurovsky, Kellen Olszewski, Boyi Gan
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nature communications 15 (1) (2024)
Taiwo Adesoye, Debasish Tripathy, Kelly K Hunt, Khandan Keyomarsi
Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics. Cancers 16 (3) (2024)
Taiwo Adesoye, Debasish Tripathy, Kelly K Hunt, Khandan Keyomarsi
Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics. Cancers 16 (3) (2024)
Mi Li, Amriti R Lulla, Yang Wang, Spyros Tsavachidis, Fuchenchu Wang, Cansu Karakas, Tuyen Duong Thanh Nguyen, Tuyen N Bui, Marc A Pina, Mei-Kuang Chen, Sofia Mastoraki, Asha S Multani, Natalie Wall Fowlkes, Ayşegül A Şahin, C Gary Marshall, Kelly K Hunt, Khandan Keyomarsi
Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer research (2024)
Hyemin Lee, Amber D Horbath, Lavanya Kondiparthi, Jitendra Kumar Meena, Guang Lei, Shayani Dasgupta, Xiaoguang Liu, Li Zhuang, Pranavi Koppula, Mi Li, Iqbal Mahmud, Bo Wei, Philip L Lorenzi, Khandan Keyomarsi, Masha V Poyurovsky, Kellen Olszewski, Boyi Gan
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nature communications 15 (1) (2024)
Hyemin Lee, Amber D Horbath, Lavanya Kondiparthi, Jitendra Kumar Meena, Guang Lei, Shayani Dasgupta, Xiaoguang Liu, Li Zhuang, Pranavi Koppula, Mi Li, Iqbal Mahmud, Bo Wei, Philip L Lorenzi, Khandan Keyomarsi, Masha V Poyurovsky, Kellen Olszewski, Boyi Gan
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nature communications 15 (1) (2024)
Hyemin Lee, Amber D Horbath, Lavanya Kondiparthi, Jitendra Kumar Meena, Guang Lei, Shayani Dasgupta, Xiaoguang Liu, Li Zhuang, Pranavi Koppula, Mi Li, Iqbal Mahmud, Bo Wei, Philip L Lorenzi, Khandan Keyomarsi, Masha V Poyurovsky, Kellen Olszewski, Boyi Gan
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nature communications 15 (1) (2024)
Hyemin Lee, Amber D Horbath, Lavanya Kondiparthi, Jitendra Kumar Meena, Guang Lei, Shayani Dasgupta, Xiaoguang Liu, Li Zhuang, Pranavi Koppula, Mi Li, Iqbal Mahmud, Bo Wei, Philip L Lorenzi, Khandan Keyomarsi, Masha V Poyurovsky, Kellen Olszewski, Boyi Gan
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nature communications 15 (1) (2024)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. Cancer research (2023)
Amriti R Lulla, Said Akli, Cansu Karakas, Joseph A Caruso, Lucas D Warma, Natalie Wall Fowlkes, Xiayu Rao, Jing Wang, Kelly K Hunt, Stephanie S Watowich, Khandan Keyomarsi
Neutrophil elastase remodels mammary tumors to facilitate lung metastasis. Molecular cancer therapeutics (2023)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer research 83 (6) (2023)
Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q Rizvi, Xiaofeng Zheng, Bailiang Wang, Bryce P Kirby, Kathleen Kong, Michael Kahle, Timothy Anthony Yap, Ecaterina E Ileana Dumbrava, Jaffer A Ajani, Siqing Fu, Khandan Keyomarsi, Funda Meric-Bernstam
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer research 83 (6) (2023)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer research 83 (6) (2023)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer research 83 (6) (2023)
Hannah F Wingate, Khandan Keyomarsi
Distinct Mechanisms of Resistance to CDK4/6 Inhibitors Require Specific Subsequent Treatment Strategies: One Size Does Not Fit All. Cancer research 83 (19) (2023)
Tuyen Duong Thanh Nguyen, Yang Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicole M Kettner, Neeta Somaiah, Peter J Houghton, Osama R Mawlawi, Alexander J F Lazar, Kelly K Hunt, Khandan Keyomarsi
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer research 83 (6) (2023)
Juliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen N Bui, Hannah F Wingate, Akshara Singareeka Raghavendra, Yang Wang, Jing Wang, Ayşegül A Şahin, Funda Meric-Bernstam, Kelly K Hunt, Senthil Damodaran, Debasish Tripathy, Khandan Keyomarsi
Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers. Cancer research (2023)
Haoyan Li, Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin K Bakht, Wei Shi, Chenling Meng, Jie Zhang, Kaitlyn Tremble, Xin Liang, Jian H Song, Xu Feng, Vivien Van, Pingna Deng, Jared K Burks, Ana M Aparicio, Khandan Keyomarsi, Junjie Chen, Yue Lu, Himisha Beltran, Di Zhao
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2. Cancer research 82 (17) (2022)
Mi Li, Spiridon Tsavachidis, Fuchenchu Wang, Tuyen Bui, Tuyen Duong Thanh Nguyen, Linjie Luo, Asha S Multani, Melissa L Bondy, Kelly K Hunt, Khandan Keyomarsi
Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer. Oncogene (2022)
Linjie Luo, Khandan Keyomarsi
PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers. Expert opinion on investigational drugs 31 (6) (2022)
Min Jin Ha, Akshara Singareeka Raghavendra, Nicole M Kettner, Wei Qiao, Senthil Damodaran, Rachel M Layman, Kelly K Hunt, Yu Shen, Debu Tripathy, Khandan Keyomarsi
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study. International journal of cancer 150 (12) (2022)
Amriti R Lulla, Said Akli, Cansu Karakas, Min Jin Ha, Natalie W Fowlkes, Yoshitsugu Mitani, Tuyen Bui, Jing Wang, Xiayu Rao, Kelly K Hunt, Laurent Meijer, Adel K El-Naggar, Khandan Keyomarsi
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis 10 (5) (2021)
Xian Chen, Dong Yang, Jason P W Carey, Cansu Karakas, Constance Albarracin, Aysegul A Sahin, Banu K Arun, Merih Guray Durak, Mi Li, Mehrnoosh Kohansal, Tuyen N Bui, Min-Jin Ha, Kelly K Hunt, Khandan Keyomarsi
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration. Cancers 13 (7) (2021)